Research Articles
Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.
Article Title | Original Publication Date | Journal | Bone Marrow Disease |
---|---|---|---|
Phase 2 Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes | Sep 2019 | Clinical Cancer Research: an official Journal of the American Association of Cancer Research | Myelodysplastic Syndromes (MDS) |
Kidney involvement in myelodysplastic syndromes | Jun 2024 | Clinical Kidney Journal | Myelodysplastic Syndromes (MDS) |
Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities | Mar 2020 | Clinical Lymphoma , Myeloma & Leukemia | Myelodysplastic Syndromes (MDS) |
The Problem of TP53-Mutant MDS/AML | Sep 2020 | Clinical Lymphoma , Myeloma & Leukemia | Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) |
Allogeneic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes and Prevention of Relapse | Jan 2021 | Clinical Lymphoma , Myeloma & Leukemia | Myelodysplastic Syndromes (MDS) |
SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes | Jun 2020 | Clinical Lymphoma , Myeloma & Leukemia | Myelodysplastic Syndromes (MDS) |
New Approaches for Anemia in MDS | Sep 2020 | Clinical Lymphoma , Myeloma & Leukemia | Myelodysplastic Syndromes (MDS) |
Pitfalls in Assessing Response to Treatment in MDS | Sep 2020 | Clinical Lymphoma , Myeloma & Leukemia | Myelodysplastic Syndromes (MDS) |
SOHO State of the Art Updates and Next Questions: An Update on Higher Risk Myelodysplastic Syndromes | Mar 2024 | Clinical Lymphoma, Myeloma & Leukemia | Myelodysplastic Syndromes (MDS) |
Real-world Effectiveness of Azacitidine in Treatment-Naive Patients With Higher-risk Myelodysplastic Syndromes | Apr 2024 | Clinical Lymphoma, Myeloma & Leukemia | Myelodysplastic Syndromes (MDS) |